The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Vasoactive properties of CORM‐3, a novel water‐soluble carbon monoxide‐releasing molecule
Open accessAbstract
Carbon monoxide (CO), one of the end products of heme catabolism by heme oxygenase, possesses antihypertensive and vasodilatory characteristics. We have recently discovered that certain transition metal carbonyls are capable of releasing CO in biological fluids and modulate physiological functions via the delivery of CO. Because the initial compounds identified were not water soluble, we have synthesized new CO‐releasing molecules that are chemically modified to allow solubility in water. The aim of this study was to assess the vasoactive properties of tricarbonylchloro(glycinato)ruthenium(II) (CORM‐3) in vitro and in vivo. CORM‐3 produced a concentration‐dependent relaxation in vessels precontracted with phenylephrine, exerting significant vasodilatation starting at concentrations of 25–50 μM. Inactive CORM‐3, which does not release CO, did not affect vascular tone. Blockers of ATP‐dependent potassium channels (glibenclamide) or guanylate cyclase activity (ODQ) considerably reduced CORM‐3‐dependent relaxation, confirming that potassium channels activation and cGMP partly mediate the vasoactive properties of CO. In fact, increased levels of cGMP were detected in aortas following CORM‐3 stimulation. The in vitro and in vivo vasorelaxant activities of CORM‐3 were further enhanced in the presence of YC‐1, a benzylindazole derivative which is known to sensitize guanylate cyclase to activation by CO. Interestingly, inhibiting nitric oxide production or removing the endothelium significantly decreased vasodilatation by CORM‐3, suggesting that factors produced by the endothelium influence CORM‐3 vascular activities. These results, together with our previous findings on the cardioprotective functions of CORM‐3, indicate that this molecule is an excellent prototype of water‐soluble CO carriers for studying the pharmacological and biological features of CO. British Journal of Pharmacology (2004) 142, 453–460. doi:10.1038/sj.bjp.0705825
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1966) · Food and Cosmetics Toxicology · doi:10.1016/s0015-6264(66)80573-4 · Cited by 4,287
THE HEME OXYGENASE SYSTEM:A Regulator of Second Messenger Gases
Maines, M. D. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.517 · Cited by 2,505
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R. J., Flavell, R. A., & Choi, A. M. K. (2000) · Nature Medicine · doi:10.1038/74680 · Cited by 2,153
Tenhunen, R., Marver, H. S., & Schmid, R. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63477-5 · Cited by 1,357
Carbon Monoxide-Releasing Molecules: Characterization of Biochemical and Vascular Activities
Motterlini, R., Clark, J. E., Foresti, R., Sarathchandra, P., Mann, B. E., & Green, C. J. (2002) · Circulation Research · doi:10.1161/hh0202.104530 · Cited by 998
Self-citationCarbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis
Brouard, S., Otterbein, L. E., Anrather, J., Tobiasch, E., Bach, F. H., Choi, A. M. K., & Soares, M. P. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1015 · Cited by 984
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.
Morita, T., Perrella, M. A., Lee, M. E., & Kourembanas, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1475 · Cited by 707
Cardioprotective Actions by a Water-Soluble Carbon Monoxide–Releasing Molecule
Clark, J. E., Naughton, P., Shurey, S., Green, C. J., Johnson, T. R., Mann, B. E., Foresti, R., & Motterlini, R. (2003) · Circulation Research · doi:10.1161/01.res.0000084381.86567.08 · Cited by 673
Self-citationStone, J. R., & Marletta, M. A. (1994) · Biochemistry · doi:10.1021/bi00184a036 · Cited by 647 · cited 1×
“A heme spectrum of guanylate cyclase in the presence of CORM-3 was performed and we observed a shift of the heme absorption to 423 nm (not shown); this confirms that CO is released from CORM-3 and binds to guanylate cyclase, since the same shift occurs with CO gas (Stone & Marletta, 1994).”
BackgroundSato, K., Balla, J., Otterbein, L., Smith, R. N., Brouard, S., Lin, Y., Csizmadia, E., Sevigny, J., Robson, S. C., Vercellotti, G., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4185 · Cited by 461
Carbon monoxide provides protection against hyperoxic lung injury
Otterbein, L. E., Mantell, L. L., & Choi, A. M. K. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.4.l688 · Cited by 436
Does carbon monoxide have a physiological function?
Marks, G. S., Brien, J. F., Nakatsu, K., & McLaughlin, B. E. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90544-3 · Cited by 425
Zakhary, R., Gaine, S. P., Dinerman, J. L., Ruat, M., Flavahan, N. A., & Snyder, S. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.795 · Cited by 401
Fujita, T., Toda, K., Karimova, A., Yan, S.-F., Naka, Y., Yet, S.-F., & Pinsky, D. J. (2001) · Nature Medicine · doi:10.1038/87929 · Cited by 398
Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver.
Suematsu, M., Goda, N., Sano, T., Kashiwagi, S., Egawa, T., Shinoda, Y., & Ishimura, Y. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118300 · Cited by 385
Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme.
Friebe, A., Schultz, G., & Koesling, D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01078.x · Cited by 352
Self-citationCarbon Monoxide Controls the Proliferation of Hypoxic Vascular Smooth Muscle Cells
Morita, T., Mitsialis, S. A., Koike, H., Liu, Y., & Kourembanas, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.32804 · Cited by 332
Carbon monoxide‐induced vasorelaxation and the underlying mechanisms
Wang, R., Wang, Z., & Wu, L. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701222 · Cited by 331
Motterlini, R., Gonzales, A., Foresti, R., Clark, J. E., Green, C. J., & Winslow, R. M. (1998) · Circulation Research · doi:10.1161/01.res.83.5.568 · Cited by 278
Self-citationMetal Carbonyls: A New Class of Pharmaceuticals?
Johnson, T. R., Mann, B. E., Clark, J. E., Foresti, R., Green, C. J., & Motterlini, R. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200301634 · Cited by 261
Self-citationBioactivity and Pharmacological Actions of Carbon Monoxide-Releasing Molecules
Motterlini, R., Mann, B., Johnson, T., Clark, J., Foresti, R., & Green, C. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033453785 · Cited by 256
Self-citationCarbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS
Thorup, C., Jones, C. L., Gross, S. S., Moore, L. C., & Goligorsky, M. S. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.6.f882 · Cited by 251
Sammut, I. A., Foresti, R., Clark, J. E., Exon, D. J., Vesely, M. J. J., Sarathchandra, P., Green, C. J., & Motterlini, R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702212 · Cited by 237
Self-citationAdministration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo
Guo, Y., Stein, A. B., Wu, W.-J., Tan, W., Zhu, X., Li, Q.-H., Dawn, B., Motterlini, R., & Bolli, R. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00971.2003 · Cited by 221
Self-citationResurgence of carbon monoxide: an endogenous gaseous vasorelaxing factor
Wang, R. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-76-1-1 · Cited by 201
Wiesel, P., Patel, A. P., DiFonzo, N., Marria, P. B., Sim, C. U., Pellacani, A., Maemura, K., LeBlanc, B. W., Marino, K., Doerschuk, C. M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.24.3015 · Cited by 191
Induction of Heme Oxygenase-1 Expression in Vascular Smooth Muscle Cells
Yet, S.-F., Pellacani, A., Patterson, C., Tan, L., Folta, S. C., Foster, L., Lee, W.-S., Hsieh, C.-M., & Perrella, M. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4295 · Cited by 189
Galle, J., Zabel, U., Hübner, U., Hatzelmann, A., Wagner, B., Wanner, C., & Schmidt, H. H. H. W. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702495 · Cited by 173
YC-1 Potentiates Nitric Oxide- and Carbon Monoxide-Induced Cyclic GMP Effects in Human Platelets
Friebe, A., Müllershausen, F., Smolenski, A., Walter, U., Schultz, G., & Koesling, D. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.962 · Cited by 167
Self-citationDoes Nitric Oxide Mediate the Vasodilator Activity of Nitroglycerin?
Kleschyov, A. L., Oelze, M., Daiber, A., Huang, Y., Mollnau, H., Schulz, E., Sydow, K., Fichtlscherer, B., Mülsch, A., & Münzel, T. (2003) · Circulation Research · doi:10.1161/01.res.0000100067.62876.50 · Cited by 165
HUMBERT, P., NIROOMAND, F., FISCHER, G., MAYER, B., KOESLING, D., HINSCH, K., GAUSEPOHL, H., FRANK, R., SCHULTZ, G., & BÖHME, E. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15572.x · Cited by 163
Carbon Monoxide: Innovative Anti-inflammatory Properties of an Age-Old Gas Molecule
Otterbein, L. E. (2002) · Antioxidants and Redox Signaling · doi:10.1089/152308602753666361 · Cited by 146
Carbon monoxide relaxes ileal smooth muscle through activation of guanylate cyclase
UTZ, J., & Ullrich, V. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90658-r · Cited by 126
Synthesis and Structural Characterization of Several Ruthenium Porphyrin Nitrosyl Complexes
Miranda, K. M., Bu, X., Lorković, I. M., & Ford, P. C. (1997) · Inorganic Chemistry · doi:10.1021/ic970065b · Cited by 122
Coceani, F., Kelsey, L., Seidlitz, E. P., Marks, G. S., McLaughlin, B. E., Vreman, H. J., Stevenson, D. K., Rabinovitch, M., & Ackerley, C. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700947 · Cited by 118
Carbon monoxide and vascular cell function (review).
Durante, W., & Schafer, A. I. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2.3.255 · Cited by 105
Carbon Monoxide and Cardiovascular Functions
Wang, R. (2001) · CRC Press eBooks · doi:10.1201/9781420041019 · Cited by 86
Hussain, A. S., Marks, G. S., Brien, J. F., & Nakatsu, K. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y97-150 · Cited by 80
McLaughlin, B. E., Chretien, M. L., Choi, C. H., Brien, J. F., Nakatsu, K., & Marks, G. S. (2000) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y99-145 · Cited by 35
Cited by
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
Ryter, S. W., Alam, J., & Choi, A. M. K. (2006) · Physiological Reviews · doi:10.1152/physrev.00011.2005 · Cited by 2,307
The therapeutic potential of carbon monoxide
Motterlini, R., & Otterbein, L. E. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3228 · Cited by 1,638
Self-citationCarbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications
Wu, L., & Wang, R. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.4.3 · Cited by 962
Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
Lee, S. Y., Kim, C. Y., & Nam, T.-G. (2020) · Drug Design, Development and Therapy · doi:10.2147/dddt.s275007 · Cited by 400
Sawle, P., Foresti, R., Mann, B. E., Johnson, T. R., Green, C. J., & Motterlini, R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706241 · Cited by 391
Metadata
- Authors
- Foresti, R., Hammad, J., Clark, J. E., Johnson, T. R., Mann, B. E., Friebe, A., Green, C. J., & Motterlini, R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2004-06
- Volume
- 142
- Issue
- 3
- Pages
- 453-460
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2097871217
- Cited by
- 303
- References
- 39
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.